Inactivated herpes simplex virus-1 vaccine formulated in aqueous and alcoholic extracts of propolis boosts cellular and IgG responses

Document Type : Short Communication

Authors

1 Advanced Therapy Medicinal Product (ATMP) Department, Breast Cancer Research Center, Motamed Cancer Institute, Academic Center for Education, Culture, and Research (ACECR), Tehran, Iran

2 Department of Biology, Islamic Azad University, Damghan Branch, Damghan, Iran

3 Department of Biochemistry, Faculty of Basic Sciences, Islamic Azad University, Central Tehran Branch, Tehran, Iran

4 Venom and Biotherapeutics Molecules Laboratory, Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran 1316943551, Iran

5 Department of Microbiology, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran

6 COVID-19 National Reference Laboratory, Pasteur Institute of Iran, Tehran, Iran

7 Department of Arboviruses and Viral Hemorrhagic Fevers (National Reference Laboratory), Pasteur Institute of Iran, Tehran, Iran

8 Department of Microbiology, Zanjan Branch, Islamic Azad University, Zanjan, Iran

9 Department of Microbiology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

10 Department of Microbiology, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

11 Cellular and Molecular Biology Research Center, Larestan University of Medical Sciences, Larestan, Iran

12 Recombinant Vaccine Research Center, Tehran University of Medical Sciences, Tehran, Iran

13 Immunotherapy Group, The Institute of Pharmaceutical Science (TIPS), Tehran University of Medical Science, Tehran, Iran

10.22038/ijbms.2024.75158.16289

Abstract

Objective(s): In this study, the adjuvant activity of aqueous and alcoholic extracts of propolis was examined on the inactivated herpes simplex virus-1 (HSV-1).
Materials and Methods: BALB/C mice were administered with inactivated (HSV-1; the KOS strain) plus alcoholic and aqueous extracts, followed by assessment of the cellular and humoral immune responses. 
Results: Alcoholic and aqueous extracts, as an adjuvant, revealed a significant increase in lymphocyte proliferation and cytotoxic T lymphocyte (CTL) responses versus the HSV-1 group. In addition, HSV-1 plus alcoholic extract showed a remarkable increase in IFN-γ cytokine and IFN-γ/IL-4 ratio. On the other hand, both alcoholic and aqueous extracts in the HSV-1 vaccine suppressed the IL-4 cytokine response as compared with the HSV-1 vaccine. In addition, HSV-1 plus alcoholic extract showed a significant increment in IgG1, IgG2a, and IgG2b isotypes as compared with the HSV-1 vaccine.
Conclusion: Propolis extracts seem to modulate the immune response against inactivated HSV-1 model and can be used as a suitable vaccine adjuvant or a component of a complex adjuvant against infectious diseases.

Keywords

Main Subjects

References

1. Lesmana R, Zulhendri F, Fearnley J, Irsyam IA, Rasyid R, Abidin T, et al. The Suitability of propolis as a bioactive component of biomaterials. Front pharmacol 2022;13:930515-930525.
2. Ripari N, Sartori AA, da Silva Honorio M, Conte FL, Tasca KI, Santiago KB, et al. Propolis antiviral and immunomodulatory activity: A review and perspectives for COVID-19 treatment.  J Pharm Pharmacol 2021;73:281-299.
3. Castaldo S, Capasso FJF. Propolis, an old remedy used in modern medicine. Fitoterapia 2002;73:S1-S6.
4. Khayyal M, El‐Ghazaly M, El‐Khatib A, Hatem A, De Vries P, El‐Shafei S, et al. A clinical pharmacological study of the potential beneficial effects of a propolis food product as an adjuvant in asthmatic patients. Fundam Clin Pharmacol 2003;17:93-102.
5. Orsatti CL, Missima F, Pagliarone AC, Sforcin JMJJoe. Th1/Th2 cytokines’ expression and production by propolis-treated mice. J Ethnopharmacol 2010;129:314-318.
6. Nakajima Y, Shimazawa M, Mishima S, Hara HJLs. Water extract of propolis and its main constituents, caffeoylquinic acid derivatives, exert neuroprotective effects via antioxidant actions. Life Sci 2007;80:370-377.
7. Mojarab S, Shahbazzadeh D, Moghbeli M, Eshraghi Y, Bagheri KP, Rahimi R, et al. Immune responses to HIV-1 polytope vaccine candidate formulated in aqueous and alcoholic extracts of Propolis: Comparable immune responses to Alum and Freund adjuvants. Microb Pathog 2020;140:103932.
8. Jamali A, Mahdavi M, Shahabi S, Hassan ZM, Sabahi F, Javan M, et al. Naloxone, an opioid receptor antagonist, enhances induction of protective immunity against HSV-1 infection in BALB/c mice. Microb Pathog 2007;43:217-223.
9. Najafi MF, Vahedy F, Seyyedin M, Jomehzadeh HR, Bozary KJC. Effect of the water extracts of propolis on stimulation and inhibition of different cells. Cytotechnology 2007;54:49-56.
10. Conti B, Santiago K, Cardoso E, Conte F, Golim M, Cruz M, et al. Effect of propolis on Th2 and Th17 cells: Interplay with EtxB-and LPS-treated dendritic cells. Braz J Med Biol Res 2023;56:e12659-12666.
11. Al-Hariri M. Immune’s-boosting agent: Immunomodulation potentials of propolis. J Family Community Med 2019;26:57-60.
12. Ma X, Guo Z, Li Y, Yang K, Li X, Liu Y, et al. Phytochemical constituents of propolis flavonoid, immunological enhancement, and anti-porcine parvovirus activities isolated from propolis. Front Vet Sci 2022;9:857183-857193.
13. Rostami H, Ebtekar M, Ardestani MS, Yazdi MH, Mahdavi M. Co-utilization of a TLR5 agonist and nano-formulation of HIV-1 vaccine candidate leads to increased vaccine immunogenicity and decreased immunogenic dose: A preliminary study. Immunol Lett 2017;187:19-26.
14. Savoji MA, Sereshgi MMA, Ghahari SMM, Asgarhalvaei F, Mahdavi M. Formulation of HBsAg in montanide ISA 51VG adjuvant: Immunogenicity study and monitoring long-lived humoral immune responses. Int Immunopharmacol 2021;96:107599.
15. Fischer G, Conceição FR, Leite FP, Dummer LA, Vargas GD, Hübner Sde O, et al. Immunomodulation produced by a green propolis extract on humoral and cellular responses of mice immunized with SuHV-1. Vaccine 2007;25:1250-1256.
16. Bezerra FSB, Rezende AdFS, de Oliveira Silva MT, Sena-Lopes Â, Roesch-Ely M, Henriques JAP, et al. The combination of Brazilian red propolis and recombinant protein rCP01850 in the immunoprophylaxis of Corynebacterium pseudotuberculosis infection in mice. Microb Pathog 2020;149:104354.
17. Onur E, Gökmen GG, Nalbantsoy A, Kışla D. Investigation of the supportive therapy potential of propolis extract and Lactobacillus acidophilus LA-5 milk combination against breast cancer in mice. Cytokine 2022;149:155743.
18. Sun Z, Ren Z, Yang K, Liu Z, Cao S, Deng S, et al. A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control. Nat Commun 2019;10:1-12.
19. Choopanizadeh M, Rasouli M, Keshavarz M, Kalani M. Combinations of Iranian propolis and Leishmania proteins have the potential to influence IL-4 and IFN-γ in immunized Balb/c mice. J Apic Res 2020;59:960-967.
20. Kao CM, Goymer J, Loh LN, Mahant A, Aschner CB, Herold BC. Murine model of maternal immunization demonstrates protective role for antibodies that mediate antibody-dependent cellular cytotoxicity in protecting neonates from herpes simplex virus type 1 and type 2.  J Infect Dis 2020;221:729-738.
Iranian Journal of Basic Medical Sciences
Volume 27, Issue 9
September 2024
Pages 1209-1213

Files

Share

How to cite

Statistics